Viral Vector Manufacturing Market Reach a Valuation of US$ 624.7 Mn in 2022 and growing at a CAGR of 18.7% over the Forecast Period 2032 - Persistence Market Research
November 17, 2022 09:30 ET
|
Persistence Market Research
New York, Nov. 17, 2022 (GLOBE NEWSWIRE) -- The global viral vector manufacturing market stands at reach a valuation of US$ 624.7 Mn in 2022 and is expected to grow rapidly at a CAGR of 18.7% over...
The viral vector, non-viral vector and gene therapy manufacturing market is projected to grow at a CAGR of ~15% till 2035, claims Roots Analysis
October 11, 2022 13:44 ET
|
Roots Analysis
London, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market, 2022-2035”...
Viral Vector Manufacturing Market Tripling Its Size to Cross USD 1.5 Billion by 2028 | BlueWeave Consulting
September 20, 2022 11:00 ET
|
BlueWeave Consulting and Research Pvt Ltd
New Delhi, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Global Viral Vector Manufacturing Market is surging at a robust growth rate during the forecast period, mainly due to the efficiency of viral vectors in...
Global Lentiviral Vector Manufacturing Market Size
April 12, 2022 09:00 ET
|
Global Market Estimates
Brooklyn, New York, April 12, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Lentiviral Vector Manufacturing Market is projected...
Global Adeno-Associated Viral Vector Manufacturing Market
March 23, 2022 10:00 ET
|
Global Market Estimates
Brooklyn, New York, March 23, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Adeno-Associated Viral Vector Manufacturing Market...
Viral Vector Manufacturing Market to See 17.5% Annual Growth Through 2023
October 23, 2018 06:30 ET
|
BCC Research
WELLESLEY, Mass, Oct. 23, 2018 (GLOBE NEWSWIRE) -- The increasing prevalence of genetic disorders and chronic diseases, along with a rising number of clinical trials in viral vectors, is helping to...